NPSP NPS Pharmaceutical Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NPSP NPS Pharmaceutical

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jbershad who wrote (3)	12/28/1996 12:08:00 AM
From: Dan Feiner	of 363

Jerry: MTSL is Medical Technology Stock Letter. Jim McCammant is the editor and is quoted on biotechs the way Murphy is on electronic techs. Seems like every time WSJ or other such paper needs a comment they go to him, or Murphy. I know they used to be partners in CTSL, I believe. I like McCammant. His newsletters are structured similarly to CTSL, with an explanation of one area of ned tech each issue. I get the feeling he is slightly more deliberate in his analysis and somewhat less quick to priase than Murphy. I find them good foils for each other and have made back the costs of my subscriptions many times over with each. MTSL has a web site with some back issues. I can't recall the address but the search engines should pull it up. Check it out. DF

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next